Form 4: Vicor Director Exercises, Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Vicor Corp. Director Andrew D'Amico exercised stock options and subsequently sold 1,000 shares of common stock on October 21, 2025, under a pre-arranged trading plan.
Summary
- Andrew D'Amico, a Director of VICOR CORP (VICR), reported transactions on October 21, 2025.
- D'Amico exercised 1,000 Non Qualified Stock Options at a price of $41.61 per share.
- Concurrently, D'Amico sold 1,000 shares of common stock at a price of $68.00 per share.
- The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2024.
- Following these transactions, D'Amico's direct beneficial ownership of common stock is 0 shares.
- D'Amico retains beneficial ownership of 13,582 derivative securities (Non Qualified Stock Options).
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a routine insider transaction involving the exercise of options and subsequent sale of shares under a pre-arranged 10b5-1 trading plan, which is a common practice for executive compensation and liquidity management.
Positives
- The director realized a profit from the exercise of options and subsequent sale, indicating a positive return on their equity compensation.
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which suggests a planned liquidity event rather than a reaction to new, negative information.
Negatives
- The director reduced their direct beneficial ownership of common stock by 1,000 shares, which could be perceived as a slight reduction in direct alignment with common shareholders, although it's a small amount and part of a pre-planned strategy.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This filing reports a routine insider transaction and does not provide information relevant to broader industry trends or competitor analysis.
Stakeholder Impact
- Shareholders: Minor impact as it's a routine, pre-planned transaction by a director for a relatively small number of shares, unlikely to signal a significant change in company prospects or management's view.
Key Dates
| Date | Description |
|---|---|
| 09/12/2024 | Date Rule 10b5-1 trading plan was adopted by the reporting person. |
| 05/02/2025 | Date options became exercisable (or a vesting date from which expiration is calculated). |
| 10/21/2025 | Date of option exercise and subsequent sale of common stock. |
| 10/22/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThis Form 4 reports a routine insider transaction where a director exercised options and sold a relatively small number of shares under a pre-arranged 10b5-1 plan. Such transactions are common for liquidity and diversification purposes and typically do not indicate a fundamental shift in the company's prospects or warrant a change in investment recommendation. Investors should consider this a neutral event in the context of their broader investment thesis for VICOR CORP.
Keywords
VICOR CORP, VICR, Andrew D'Amico, Form 4, Insider Trading, Stock Option Exercise, Stock Sale, Rule 10b5-1 Plan, Director Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.